|Day Low/High||1,022.20 / 1,032.87|
|52 Wk Low/High||610.71 / 1,054.77|
Here are the names we discovered.
Jim Cramer is bullish on Novartis AG, Sirius XM Radio, Coupa Software and Juno Therapeutics.
Jim Cramer says the calendar and the momentum holders are coalescing to produce selling. Here's what investors should do about it.
JustRight Surgical, LLC, the company pioneering mini-laparoscopic surgical instruments, today announced it has entered into a licensing agreement with Intuitive Surgical (NASDAQ: ISRG), a global technology leader in...
Jim Cramer is bullish on Philip Morris, 3M and Becton Dickinson; but he's bearish on Blue Apron and Puma Biotechnology.
Jim Cramer says history doesn't have to repeat itself. You don't want to miss another opportunity in the highly visible FANG-style stocks.
In these turbulent times, Jim Cramer wants to help you by sharing his investing methods.
Everything you must know about the market right now is here.
Jim Cramer says the story is less about Comey vs. Trump than it is about Nvidia vs. Nordstrom.
This marks the first time that the FDA is seeking to remove an opioid pain medication from the market due to the public health consequences of abuse.
TheStreet's Action Alerts PLUS Portfolio Manager Jim Cramer is bringing back his "CANDIES" market acronym.
NewLink Genetics, Inovio Pharmaceuticals and Juno Therapeutics were among the biotech stock movers in premarket trading on Thursday.
Comey's testimony? U.K. elections? Eurozone news? These can be new buying opportunities, says Jim Cramer.
I was pleasantly surprised to see that the candies are still crushing it.
The handwringers will be out in full force. Their fear creates buying opportunities.
New da Vinci X™ Surgical System provides lower-cost, robotic-assisted surgical option for hospitals, surgeons
Shares of Intuitive Surgical were trading in the red on Tuesday morning.
Here are Tuesday's top research calls, including downgrades for Ambarella and BlackBerry, and upgrades for PVH Corp. and Zynga.
The most recent short interest data has been released for the 05/15/2017 settlement date, and we here at Dividend Channel like to sift through this fresh data and order the underlying components of the Nasdaq 100 by "days to cover." There are a number of ways to look at short data, for example the total number of shares short; but one metric that we find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares typically traded. The number of shares short is then compared to the average daily volume, in order to calculate the total number of trading days it would take to close out all of the open short positions if every share traded represented a short position being closed.
Goldman Sachs initiates coverage on the medical equipment company with a buy rating and a $1,000 price target. Can shares get there?
From Abbott Labs to Wynn, these names rate checking out.
It's a wonder to me how split this market really is.
Sign up to get started or log in to see your watchlist.
Enter a symbol above to add it to your watchlist.
A confirmation email has been sent to the address provided during registration. Please click on the appropriate link to confirm your email address.